Fipamezole (INN; developmental code names BVF-025 and JP-1730) is an α2-adrenergic receptor antagonist which was under development for the treatment of Parkinson's disease but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.